Korean J Gastroenterol.
2022 Jan;79(1):52-53. 10.4166/kjg.2014.059.e1.
Comparison on the Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid in Patients with Abnormal Alanine Aminotransferase: Multicenter, Double-blinded, Randomized, Active-controlled Clinical Trial
- Affiliations
-
- 1Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
- 2Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
- 3Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
- 4Soonchunhyang University Seoul Hospital, Seoul, Korea
- 5Soonchunhyang University College of Medicine, Seoul, Korea
- KMID: 2525525
- DOI: http://doi.org/10.4166/kjg.2014.059.e1
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Comparison on the Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid in Patients with Abnormal Alanine Aminotransferase: Multicenter, Double-blinded, Randomized, Active-controlled Clinical Trial
- The PERFECT Study (PEnnel Real liFe Efficacy Clinical Trial), a Double-Blind, Randomized, Multicenter Trial Examining the Efficacy of Biphenyl Dimethyl Dicarboxylate Combined with Garlic Oil in Patients with Transaminase Elevated Chronic Liver Disease
- Prospective, randomized, controlled trial with diphenyl-dimethyl- dicarboxylate in chronic active liver diseases; the effet on lowering serum alanine aminotransferase levels
- Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid Combination in Chronic Hepatitis Related to Metabolic Syndrome Components
- A Study on the Efficacy and Safety of Dipheny-dimethyl-dicarboxylate in Patients with Chronic Liver disease
